PHP32 OBTAINING VALUE FOR MONEY FROM PHARMACEUTICALS: REFERENCE PRICING OR HEALTH TECHNOLOGY ASSESSMENT?
نویسندگان
چکیده
منابع مشابه
Pharmaceuticals: Reference Pricing or Price Cap Regulation?
We study the relationship between regulatory regimes and pharmaceutical firms’ pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” for a sub-sample of off-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel dataset, cov...
متن کاملReference pricing of pharmaceuticals.
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry costs. The other brand-name drug has already lost its patent and faces competition from a third firm offer...
متن کاملReference pricing with elastic demand for pharmaceuticals∗
This paper analyzes pharmaceutical producers’(of branded and generic drugs) pricing decisions in a context which combines the classical Hotelling framework (commonly adopted in the literature) with the possibility that consumers’demands are price elastic. We analyze with particular interest two commonly adopted reimbursement mechanisms: fixed percentage reimbursement (FPR) and reference pricing...
متن کاملUse of a decision-analytic model in a health technology assessment: beyond measuring value for money
The well-designed, model-based cost-utility analysis by Ginsberg and colleagues provides useful information on the value for money of universal GBS screening in Israel. An extended application of the model-based approach used in the study could provide policymakers additional practical information on the budget impact of a potential universal GBS screening program. Such an approach could also b...
متن کاملPrioritizing investments in health technology assessment. Can we assess potential value for money?
OBJECTIVE The objective was to develop an economic prioritization model to assist those involved in the selection and prioritization of health technology assessment topics and commissioning of HTA projects. METHODS The model used decision analytic techniques to estimate the expected costs and benefits of the health care interventions that were the focus of the HTA question(s) considered by th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2007
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)65310-7